Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural Steroids for Maternal Fever Prevention
NCT02212210Phase 1Terminated
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2012
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of methylprednisolone in inflammation (2 arms), sponsored by Medical University of South Carolina. Primary endpoint: Rate of maternal fever. Started Feb 2012; status: terminated.
02
Drugs
methylprednisolone
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT02212210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212210.